GABA and glutamate in migraine

Journal of Headache and Pain

Volumn 2, Issue SUPPL. 1, 2001, Pages

  D'Andrea, Giovanni ^a   Granella, Franco ^b   Cataldini, Morena ^a   Verdelli, Flavio ^a   Balbi, Tiziana ^a  

^a Este Monselice Hospital   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

GABA; Glutamic acid; Migraine pathogenesis; Migraine with and without aura

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; ANTIMIGRAINE AGENT; BIOCHEMICAL MARKER; GABAPENTIN; GLUTAMIC ACID; KETAMINE; LAMOTRIGINE; NEUROTRANSMITTER; PLACEBO; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; GABAERGIC SYSTEM; HUMAN; METABOLISM; MIGRAINE; NERVE EXCITABILITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE;

EID: 0034786725     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101940170011     Document Type: Article

References (35)

1. Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography
2. Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge
3. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat sagittal sinus during electrical stimulation of trigeminal ganglion
4. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats
5. Platelet activity in migraine
6. Nitric oxide involvement in migraine
7. Perivascular meningeal projections from cat trigeminal ganglia: Possible pathway for vascular headache in man
8. Locus coeruleus, an integrative station involved in the control of several vital functions
9. Sensory, motivational and central control determinants of pain. A new conceptual model
10. Peripheral and spinal mechanisms of nociception
11. Disorders of membrane channels or channelopathies
12. GABAA receptor channels
13. Multiple GABAB receptors
14. Inhibition of nociception
15. Glutametergic neuro-transmission in aging: A critical prospective
16. Cerebrospinal fluid gamma aminobutyric acid levels in migraine
17. Platelet gamma-aminobutyric acid levels in migraine and tension-type headache
18. Salivary substance P, 5-hydroxytryptamine and gamma-aminobutyric acid levels in migraine and tension-type headaches
19. Possible mechanisms of valproate in migraine prophylaxis
20. Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo
21. Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebo-crossover study
22. Divalproex sodium in migraine prophylaxis: A dose-controlled study
23. Valproate in the treatment of persistent chronic daily headache: An open label study
24. Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study
25. Platelet levels of glutamate and aspartate in normal subjects
26. The concept of migraine as a state of central neuronal hyperexcitability
27. The human platelet as a model for glutamatergic neuron: Platelet uptake of L-glutamate
28. Platelet glycine, glutamate and aspartate in primary headaches
29. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura
30. Anticonvulsant profile in mice of lamotrigine, a novel anticonvulsant
31. Lamotrigine: Historical background
32. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura
33. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: A open pilot study
34. Lamotrigine in the prophylactic treatment migraine with aura - A pilot study
35. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine